\begin{tabular}{|l|l|l|l|l|l|l|l|l|l|l|}
\hline
\rowcolor[gray]{.85}{}                           & \textbf{$a_0$} & \textbf{$b_0$} & \textbf{$c_0$} & \textbf{$d_0$} & \textbf{$a_1$} & \textbf{$b_1$} & \textbf{$c_1$} & \textbf{$d_1$} & \textbf{PPA} & \textbf{                          NPA }\\ \hline
BRAF Activating SNV         &      0 &      0 &      1 &    150 &      5 &      0 &      0 &      0 &  100.0 (100.0 - 100.0) &    99.338 (97.973 - 100.000) \\ \hline
BRCA1 Inactivating SNV      &      1 &      0 &      2 &   4501 &     13 &      2 &      2 &      3 &    97.5 (72.2 - 100.0) &    99.955 (99.888 - 100.000) \\ \hline
BRCA2 Inactivating SNV      &      1 &      0 &      0 &   2799 &      8 &      0 &      0 &      0 &  100.0 (100.0 - 100.0) &  100.000 (100.000 - 100.000) \\ \hline
EGFR L858R                  &      0 &      0 &      1 &    151 &      4 &      0 &      0 &      0 &  100.0 (100.0 - 100.0) &    99.342 (97.987 - 100.000) \\ \hline
EGFR T790M                  &      0 &      0 &      1 &    143 &      9 &      1 &      1 &      1 &    90.0 (66.7 - 100.0) &    99.079 (97.384 - 100.000) \\ \hline
KRAS Activating SNVs        &      2 &      1 &      1 &   2000 &     20 &      1 &      1 &      2 &    88.2 (70.9 - 100.0) &    99.928 (99.775 - 100.000) \\ \hline
NRAS Activating SNVs        &      0 &      1 &      0 &   1709 &      5 &      1 &      0 &      0 &    52.8 (19.9 - 100.0) &  100.000 (100.000 - 100.000) \\ \hline
Other EGFR activating SNVs  &      0 &      0 &      0 &    922 &     14 &      0 &      0 &      0 &  100.0 (100.0 - 100.0) &  100.000 (100.000 - 100.000) \\ \hline
BRCA2 Inactivating Indel    &      4 &      7 &      9 &   8689 &     18 &      2 &      1 &      6 &    39.1 (12.0 - 100.0) &     99.896 (99.757 - 99.989) \\ \hline
BRCA1 Inactivating Indel    &      0 &      1 &      1 &   3410 &     12 &      3 &      3 &      2 &      15.6 (4.4 - 94.1) &    99.969 (99.910 - 100.000) \\ \hline
EGFR Activating Indel       &      0 &      0 &      0 &   1234 &     12 &      0 &      1 &      1 &  100.0 (100.0 - 100.0) &    99.994 (99.981 - 100.000) \\ \hline
ERBB2 Activating Indel      &      0 &      0 &      0 &    464 &      4 &      0 &      0 &      0 &  100.0 (100.0 - 100.0) &  100.000 (100.000 - 100.000) \\ \hline
Other EGFR activating Indel &      0 &      0 &      0 &   1401 &      2 &      0 &      0 &      1 &  100.0 (100.0 - 100.0) &  100.000 (100.000 - 100.000) \\ \hline
Homopolymer                 &      4 &      9 &      4 &  37682 &     41 &      3 &      2 &      7 &     48.2 (33.0 - 74.5) &     99.989 (99.978 - 99.997) \\ \hline
Long Indel                  &      0 &      2 &      4 &   3880 &     10 &      1 &      0 &      3 &      7.7 (3.0 - 100.0) &    99.897 (99.716 - 100.000) \\ \hline
ERBB2 Amplification         &      3 &      1 &      0 &    152 &      0 &      0 &      0 &      0 &                     NA &                           NA \\ \hline
MET Amplification           &     14 &      5 &      1 &    136 &      0 &      0 &      0 &      0 &                     NA &                           NA \\ \hline
NTRK1 Fusion                &      0 &      0 &      0 &    147 &      5 &      0 &      0 &      4 &  100.0 (100.0 - 100.0) &  100.000 (100.000 - 100.000) \\ \hline
RET Fusion                  &      0 &      1 &      0 &    609 &     11 &      0 &      2 &      1 &    63.3 (33.6 - 100.0) &    99.949 (99.871 - 100.000) \\ \hline
ROS1 Fusion                 &      0 &      0 &      0 &    613 &     11 &      0 &      0 &      0 &  100.0 (100.0 - 100.0) &  100.000 (100.000 - 100.000) \\ \hline
ALK Fusion                  &      0 &      0 &      0 &    147 &      7 &      0 &      2 &      0 &  100.0 (100.0 - 100.0) &    99.773 (99.445 - 100.000) \\ \hline
\end{tabular}